ATLANTHERA is a drug discovery company with a focus on bone diseases and bone cancer treatments. The company's slogan is "Bone targeted delivery concept," which aligns with its vision to be the leader in bone-targeted drug delivery to cure bone cancer and metastases. Founded in 2011 and headquartered in France, Atlanthera boasts a highly qualified team and a worldwide-known experts network. Their concept revolves around bone-targeted delivery of anti-cancer drugs. The last investment of €800.00K came in the form of a Venture Round investment on 15 April 2014, with Go Capital being the investor. For more information, visit their website www.atlanthera.com or watch their concept video at https://youtu.be/m3BBWguO6hs.
No recent news or press coverage available for ATLANTHERA.